Rainbow Seed Fund News

Collaboration to generate tumor targeting drug conjugates and immuno-oncology therapeutics Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody®-based therapeutics, and Takeda Pharmaceutical Company Limited (TSE: 4502) today announced a global, strategic, multi-target collaboration and license agreement for the discovery, development and commercialization of Humabody® -based therapeutics for cancer indications with a high unmet medical […]

read more

SynbiCITE and Rainbow Seed Fund today announce that Sir Richard Sykes, Chairman of the Royal Institution of Great Britain, Chairman of Imperial College Healthcare and Chancellor of Brunel University, will act as Chair of judges for theBio-start competition judging panel in 2017. Bio-start, a new annual competition founded by SynbiCITE and Rainbow Seed Fund, aims to incentivize innovative early-stage […]

read more

AgPlus’ handheld electrochemical reader to deliver the next generation of rapid diagnostics Rainbow Seed Fund, an early-stage venture capital fund focused on promising technologies developed at the UK’s largest publicly-funded research facilities and campuses, today announces its investment into AgPlus Diagnostics, a technology platform developed by scientists at the UK’s National Physical Laboratory (NPL). AgPlus’ […]

read more

1 2 3 4 5 19